Hypoxia-related Y RNA fragments as a novel potential biomarker for distinguishing metastatic oral melanoma from non-metastatic oral melanoma in dogs

References

• Barreca MM, Zichittella C, Alessandro R, Conigliaro A. 2021. Hypoxia-induced non-coding RNAs controlling cell viability in cancer. Int J Mol Sci. 22(4):1857. doi: 10.3390/ijms22041857.
   Web of Science ®Google Scholar
• Bister N, Pistono C, Huremagic B, Jolkkonen J, Giugno R, Malm T. 2020. Hypoxia and extracellular vesicles: a review on methods, vesicular cargo and functions. J Extracell Vesicles. 10(1):e12002. doi: 10.1002/jev2.12002.
   PubMed Web of Science ®Google Scholar
• Christov CP, Trivier E, Krude T. 2008. Noncoding human Y RNAs are overexpressed in tumours and required for cell proliferation. Br J Cancer. 98(5):981–988. doi: 10.1038/sj.bjc.6604254.
   PubMed Web of Science ®Google Scholar
• Dhahbi JM, Spindler SR, Atamna H, Boffelli D, Mote P, Martin DI. 2013. 5’-YRNA fragments derived by processing of transcripts from specific YRNA genes and pseudogenes are abundant in human serum and plasma. Physiol Genomics. 45(21):990–998. doi: 10.1152/physiolgenomics.00129.2013.
   PubMed Web of Science ®Google Scholar
• Emami Nejad A, Najafgholian S, Rostami A, Sistani A, Shojaeifar S, Esparvarinha M, Nedaeinia R, Haghjooy Javanmard S, Taherian M, Ahmadlou M, et al. 2021. The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment. Cancer Cell Int. 21(1):62. doi: 10.1186/s12935-020-01719-5.
   PubMed Web of Science ®Google Scholar
• Gardiner TJ, Christov CP, Langley AR, Krude T. 2009. A conserved motif of vertebrate Y RNAs essential for chromosomal DNA replication. RNA. 15(7):1375–1385. doi: 10.1261/rna.1472009.
   PubMed Web of Science ®Google Scholar
• Guglas K, Kołodziejczak I, Kolenda T, Kopczyńska M, Teresiak A, Sobocińska J, Bliźniak R, Lamperska K. 2020. YRNAs and YRNA-derived fragments as new players in cancer research and their potential role in diagnostics. Int J Mol Sci. 21 (16):5682. doi: 10.3390/ijms21165682.
   Web of Science ®Google Scholar
• Hardwick L. 2021. A comparative view on molecular alterations and potential therapeutic strategies for canine oral melanoma. Vet Sci. 8(11):286. doi: 10.3390/vetsci8110286.
   PubMed Web of Science ®Google Scholar
• Hino Y, Rahman MM, Lai YC, Husna AA, Chen HW, Hasan MN, Nakagawa T, Miura N. 2021. Hypoxic miRNAs expression are different between primary and metastatic melanoma cells. Gene. 782:145552. doi: 10.1016/j.gene.2021.145552.
   PubMed Web of Science ®Google Scholar
• Husna AA, Rahman MM, Lai YC, Chen HW, Hasan MN, Nakagawa T, Miura N. 2021. Identification of melanoma-specific exosomal miRNAs as the potential biomarker for canine oral melanoma. Pigment Cell Melanoma Res. 34(6):1062–1073. doi: 10.1111/pcmr.13000.
   PubMed Web of Science ®Google Scholar
• Inoue K, Ohashi E, Kadosawa T, Hong SH, Matsunaga S, Mochizuki M, Nishimura R, Sasaki N. 2004. Nov. Establishment and characterization of four canine melanoma cell lines. J Vet Med Sci. 66(11):1437–1440. doi: 10.1292/jvms.66.1437.
   PubMed Web of Science ®Google Scholar
• Iussich S, Maniscalco L, Di Sciuva A, Iotti B, Morello E, Martano M, Gattino F, Buracco P, De Maria R. 2017. PDGFRs expression in dogs affected by malignant oral melanomas: correlation with prognosis. Vet Comp Oncol. 15(2):462–469. doi: 10.1111/vco.12190.
   PubMed Web of Science ®Google Scholar
• Kowalski MP, Krude T. 2015. Functional roles of non-coding Y RNAs. Int J Biochem Cell Biol. 66:20–29. doi: 10.1016/j.biocel.2015.07.003.
   PubMed Web of Science ®Google Scholar
• Li C, Wang W, Sun Y, Ni Y, Qin F, Li X, Wang T, Guo M, Sun G. 2022. Selective sorting and secretion of hY4 RNA fragments into extracellular vesicles mediated by methylated YBX1 to promote lung cancer progression. J Exp Clin Cancer Res. 41(1):136. doi: 10.1186/s13046-022-02346-w.
   PubMed Web of Science ®Google Scholar
• Lunavat TR, Cheng L, Kim DK, Bhadury J, Jang SC, Lässer C, Sharples RA, López MD, Nilsson J, Gho YS, et al. 2015. Small RNA deep sequencing discriminates subsets of extracellular vesicles released by melanoma cells: evidence of unique microRNA cargos. RNA Biol. 12(8):810–823. doi: 10.1080/15476286.2015.1056975.
   PubMed Web of Science ®Google Scholar
• Palma SD, McConnell A, Verganti S, Starkey M. 2021. Review on canine oral melanoma: an undervalued authentic genetic model of human oral melanoma? Vet Pathol. 58(5):881–889. doi: 10.1177/0300985821996658.
   PubMed Web of Science ®Google Scholar
• Peng Q, Wang J. 2021. Non-coding RNAs in melanoma: biological functions and potential clinical applications. Mol Ther Oncol. 22:219–231. doi: 10.1016/j.omto.2021.05.012.
   PubMed Web of Science ®Google Scholar
• Pinto C, Aluai-Cunha C, Santos A. 2023. The human and animals’ malignant melanoma: comparative tumor models and the role of microbiome in dogs and humans. Melanoma Res. 33(2):87–103. doi: 10.1097/CMR.0000000000000880.
   PubMed Web of Science ®Google Scholar
• Rahman MM, Lai YC, Husna AA, Chen HW, Tanaka Y, Kawaguchi H, Hatai H, Miyoshi N, Nakagawa T, Fukushima R, et al. 2020. Aberrantly expressed snoRNA, snRNA, piRNA and tRFs in canine melanoma. Vet Comp Oncol. 18(3):353–361. doi: 10.1111/vco.12558.
   PubMed Web of Science ®Google Scholar
• Rahman MM, Lai YC, Husna AA, Chen HW, Tanaka Y, Kawaguchi H, Miyoshi N, Nakagawa T, Fukushima R, Miura N. 2019. Micro RNA transcriptome profile in canine oral melanoma. Int J Mol Sci. 20(19):4832. doi: 10.3390/ijms20194832.
   Web of Science ®Google Scholar
• Rankin EB, Giaccia AJ. 2016. Hypoxic control of metastasis. Science. 352(6282):175–180. doi: 10.1126/science.aaf4405.
   PubMed Web of Science ®Google Scholar
• Riefolo M, Porcellini E, Dika E, Broseghini E, Ferracin M. 2019. Interplay between small and long non-coding RNAs in cutaneous melanoma: a complex jigsaw puzzle with missing pieces. Mol Oncol. 13(1):74–98. doi: 10.1002/1878-0261.12412.
   PubMed Web of Science ®Google Scholar
• Rogers N. 2015. Canine clues: dog genomes explored in effort to bring human cancer to heel. Nat Med. 21(12):1374–1375. doi: 10.1038/nm1215-1374.
   PubMed Web of Science ®Google Scholar
• Solé C, Tramonti D, Schramm M, Goicoechea I, Armesto M, Hernandez LI, Manterola L, Fernandez-Mercado M, Mujika K, Tuneu A, et al. 2019. The circulating transcriptome as a source of biomarkers for melanoma. Cancers (Basel). 11(1):70. doi: 10.3390/cancers11010070.
   PubMed Web of Science ®Google Scholar
• Tolkach Y, Niehoff EM, Stahl AF, Zhao C, Kristiansen G, Müller SC, Ellinger J. 2018. YRNA expression in prostate cancer patients: diagnostic and prognostic implications. World J Urol. 36(7):1073–1078. doi: 10.1007/s00345-018-2250-6.
   PubMed Web of Science ®Google Scholar
• Tolkach Y, Stahl AF, Niehoff EM, Zhao C, Kristiansen G, Müller SC, Ellinger J. 2017. YRNA expression predicts survival in bladder cancer patients. BMC Cancer. 17(1):749. doi: 10.1186/s12885-017-3746-y.
   PubMed Web of Science ®Google Scholar
• Treggiari E, Grant JP, North SM. 2016. A retrospective review of outcome and survival following surgery and adjuvant xenogeneic DNA vaccination in 32 dogs with oral malignant melanoma. J Vet Med Sci. 78(5):845–850. doi: 10.1292/jvms.15-0510.
   PubMed Web of Science ®Google Scholar
• Turek M, LaDue T, Looper J, Nagata K, Shiomitsu K, Keyerleber M, Buchholz J, Gieger T, Hetzel S. 2020. Multimodality treatment including ONCEPT for canine oral melanoma: a retrospective analysis of 131 dogs. Vet Radiol Ultrasound. 61(4):471–480. doi: 10.1111/vru.12860.
   PubMed Web of Science ®Google Scholar